NRXP
NASDAQ · Pharmaceuticals
Nrx Pharmaceuticals Inc
$2.33
+0.06 (+2.64%)
Open$2.30
Previous Close$2.27
Day High$2.33
Day Low$2.26
52W High$5.06
52W Low$1.62
Volume—
Avg Volume2.67M
Market Cap101.75M
P/E Ratio—
EPS$-0.74
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+813.3% upside
Current
$2.33
$2.33
Target
$21.28
$21.28
$14.65
$21.28 avg
$27.46
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.50M | 21.55M | 19.28M |
| Net Income | -58,400,785 | 2.70M | 1.92M |
| Profit Margin | -2,336.5% | 12.5% | 10.0% |
| EBITDA | -45,610,602 | 4.73M | 4.55M |
| Free Cash Flow | — | 2.93M | 1.59M |
| Rev Growth | — | +2.0% | +3.7% |
| Debt/Equity | 1.42 | 0.67 | 0.51 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |